Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04801381
NA

WATER III: Aquablation vs. Transurethral Laser Enucleation of Large Prostates (80 - 180mL) in Benign Prostatic Hyperplasia

Sponsor: University of Bonn

View on ClinicalTrials.gov

Summary

Comparative analysis of efficacy and safety of Aquablation (AQUABEAM Robotic System®, PROCEPT BioRobotics, Redwood City, CA, USA) and transurethral laser enucleation as surgical therapy for benign prostatic hyperplasia with large prostates (80-180ml).

Official title: WATER III: Aquablation vs. Transurethral Laser Enucleation of Large Prostates (80-180ml) in Benign Prostatic Hyperplasia

Key Details

Gender

MALE

Age Range

45 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

202

Start Date

2020-12-16

Completion Date

2029-10

Last Updated

2025-02-06

Healthy Volunteers

No

Interventions

PROCEDURE

Aquablation therapy

Aquablation is carried out with the AQUABEAM Robotic System®, PROCEPT BioRobotics, Redwood City, CA, USA

PROCEDURE

Transurethral laser enucleation

Transurethral laser enucleation is performed according to the standard established at the respective test center. Included laser techniques: Holmium laser (HoLEP) and Thulium laser (ThuLEP).

Locations (5)

Department of Urology, University Hospital Freiburg

Freiburg im Breisgau, Baden-Wurttemberg, Germany

Department of Urology, Augusta-Kranken-Anstalt, Bochum Mitte

Bochum, North Rhine-Westphalia, Germany

Department of Urology, University Hospital Bonn

Bonn, North Rhine-Westphalia, Germany

Frimley Health NHS Foundation Trust

London, United Kingdom

Guy's and St. Thomas' Hospital

London, United Kingdom